1. Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study. (8th May 2020) Authors: Georgakopoulos, J.R.; Lam, K.; Sandhu, V.K.; Ighani, A.; Phung, M.; Piguet, V.; Yeung, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 8(2020) Page Start: e416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hydroxychloroquine: do we all see eye to eye? A single-site analysis of hydroxychloroquine dosing compared with the 2016 Revision of the American Academy of Ophthalmology guidelines. (March 2019) Authors: Sandhu, V.K.; Goel, N.; Duro, T Journal: Lupus Issue: Volume 28:Number 3(2019) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of hidradenitis suppurativa on work productivity and activity impairment. (11th December 2019) Authors: Sandhu, V.K.; Shah, M.; Piguet, V.; Alavi, A. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The impact of hidradenitis suppurativa on work productivity and activity impairment. (1st May 2020) Authors: Sandhu, V.K.; Shah, M.; Piguet, V.; Alavi, A. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗